{"title":"Cerebrovascular disease associated with Parkinson’s disease in Moldovan cohort study","authors":"L. Rotaru","doi":"10.52418/moldovan-med-j.64-6.21.06","DOIUrl":null,"url":null,"abstract":"Background: Parkinson’s disease (PD) is frequently associated with brain vascular lesions (BVLs), which may influence the severity of the disease. Material and methods: BVLs on MRI were determined in 78.4% of 111 consecutive PD patients (mean age 64.87 ± 7.69 y.o.; disease duration 50.21 ± 38.61 mo.; 48 women (43.2%), 63 men (56.8%)). Results: White matter lesions were present in 73 patients (p.) (65.77%): 61p. (54.95%) – deep white matter, 46p. (41.44%) – periventricular white matter, and 41p. (36.94%) – both locations. Lacunas were determined in 19p. (17.12%), cerebral fissures deepening – 52p. (46.85) %), perivascular spaces dilation – 34p. (30.63%), ventricular system dilation – 29p. (26.13%). Patients with and without BVLs had similar ages, ages at PD onset and disease duration. They had insignificantly higher Beck (7.26 ± 5.62 vs 6.86 ± 4.34), PDQ39 (Parkinson’s Disease Questionnaire) (59.71 ± 20.38 vs 51.94 ± 27.69) and NMS (Non-Motor Symptoms) (75.06 ± 45.21 vs 71.67 ± 26.35) scores; and lower MoCA (Montreal Cognitive Assessment) scores (21.92 ± 4.25 vs 22.38 ± 4.57). QRISK3 scores (19.68 ± 16.16 vs 12.90 ± 6.58) and levodopa equivalent daily dose (639.98 ± 223.05 vs. 439.69 ± 404.87) were significantly higher in patients with BVLs. Conclusions: Brain vascular lesions were common in our PD patients, and were associated with higher QRISK3 scores and higher levodopa equivalent daily dose, suggesting more disease severity","PeriodicalId":32733,"journal":{"name":"The Moldovan Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Moldovan Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52418/moldovan-med-j.64-6.21.06","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Parkinson’s disease (PD) is frequently associated with brain vascular lesions (BVLs), which may influence the severity of the disease. Material and methods: BVLs on MRI were determined in 78.4% of 111 consecutive PD patients (mean age 64.87 ± 7.69 y.o.; disease duration 50.21 ± 38.61 mo.; 48 women (43.2%), 63 men (56.8%)). Results: White matter lesions were present in 73 patients (p.) (65.77%): 61p. (54.95%) – deep white matter, 46p. (41.44%) – periventricular white matter, and 41p. (36.94%) – both locations. Lacunas were determined in 19p. (17.12%), cerebral fissures deepening – 52p. (46.85) %), perivascular spaces dilation – 34p. (30.63%), ventricular system dilation – 29p. (26.13%). Patients with and without BVLs had similar ages, ages at PD onset and disease duration. They had insignificantly higher Beck (7.26 ± 5.62 vs 6.86 ± 4.34), PDQ39 (Parkinson’s Disease Questionnaire) (59.71 ± 20.38 vs 51.94 ± 27.69) and NMS (Non-Motor Symptoms) (75.06 ± 45.21 vs 71.67 ± 26.35) scores; and lower MoCA (Montreal Cognitive Assessment) scores (21.92 ± 4.25 vs 22.38 ± 4.57). QRISK3 scores (19.68 ± 16.16 vs 12.90 ± 6.58) and levodopa equivalent daily dose (639.98 ± 223.05 vs. 439.69 ± 404.87) were significantly higher in patients with BVLs. Conclusions: Brain vascular lesions were common in our PD patients, and were associated with higher QRISK3 scores and higher levodopa equivalent daily dose, suggesting more disease severity
背景:帕金森病(PD)经常与脑血管病变(BVL)有关,这可能会影响疾病的严重程度。材料和方法:在111例连续PD患者中,78.4%的患者(平均年龄64.87±7.69岁;病程50.21±38.61个月;48名女性(43.2%),63名男性(56.8%))在MRI上检测到BVL。(54.95%)-深白质,46便士。(41.44%)-室周白质和41p。(36.94%)-两个地点。在19p中测定了漆酶。(17.12%),脑裂加深-52p。(46.85)%),血管周围间隙扩张–34p。(30.63%),心室系统扩张-29p。(26.13%)。患有和不患有BVL的患者具有相似的年龄、PD发病年龄和疾病持续时间。他们的Beck(7.26±5.62 vs 6.86±4.34)、PDQ39(帕金森病问卷)(59.71±20.38 vs 51.94±27.69)和NMS(非运动症状)(75.06±45.21 vs 71.67±26.35)得分不显著升高;BVL患者的MoCA(蒙特利尔认知评估)评分较低(21.92±4.25 vs 22.38±4.57)。QRISK3评分(19.68±16.16 vs 12.90±6.58)和左旋多巴等效日剂量(639.98±223.05 vs 439.69±404.87)显著较高。结论:脑血管病变在我们的PD患者中很常见,并且与较高的QRISK3评分和较高的左旋多巴当量日剂量有关,表明疾病更严重